According to the Zhitong Finance App, Shenwei Pharmaceutical (02877.HK) announced its 2026 interim results. The group achieved a turnover of 1,181 million yuan, a year-on-year decrease of 28.5%; profit for the period of 469 million yuan, a decrease of 23.7%; basic profit per share of 62 points; and plans to distribute a second interim dividend of 80 points.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.